Endologix Inc. (ELGX) belonging to the Medical sector has surged 5.56% and closed its last trading session at $6.84.
The company reported its EPS on 02/22/2017. Currently, the stock has a 1 Year Price Target of $8.18.
The consensus recommendation, according to Zacks Investment research, is 2. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.
The Stock had a 1.89 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1.89 and 1.89 respectively.
Endologix Inc. on 02/22/2017 reported its EPS as $-0.22 with the analysts projecting the EPS of the stock as $-0.19. The company beat the analyst EPS Estimate with the difference of $-0.03. This shows a surprise factor of -15.8%.
Many analysts have provided their estimated foresights on Endologix Inc. Earnings, with 10 analysts believing the company would generate an Average Estimate of $-0.22.
Whereas they predicted High and Low Earnings Estimate as $-0.15 and $-0.28 respectively. While in the same Quarter Previous year, the Actual EPS was $-0.25.
Analysts are also projecting an Average Revenue Estimate for Endologix Inc. as $41.02 Million in the Current Quarter. This estimate is provided by 10 analysts.
The High Revenue estimate is predicted as 42 Million, while the Low Revenue Estimate prediction stands at 39.9 Million. The company’s last year sales total was 42.37 Million.
For the Current Quarter, the growth estimate for Endologix Inc. is 12%, while for the Next Quarter the stock growth estimate is 25%.
The Company got Downgrade by Canaccord Genuity on 17-Nov-16 from Buy to Hold.
Insider Trades for Endologix Inc. show that the latest trade was made on 26 Feb 2017 where Mahboob (Vaseem), the Chief Financial Officer completed a transaction type “Buy” in which 55310 shares were traded at a price of $0.
6 Insider Sales transactions were made totaling 69688 shares traded.
10 analysts projected Price Targets for Endologix Inc.. The analysts believe that the company stock price could grow as high as $10. The Low Price target projection by analysts is $5.75 and the Mean Price Target is $8.18.
Endologix Inc. (ELGX) has the market capitalization of $559.1 Million. The company rocked its 52-Week High of $14.5 on Jul 12, 2016 and touched its 52-Week Low of $4.78 on Dec 28, 2016.
The stock has Return on Assets (ROA) of -40.3 percent. Return on Equity (ROE) stands at -117.7% and Return on Investment (ROI) of -32.1 percent.
The stock is currently showing YTD performance of 19.58 Percent. The company has Beta Value of 0.81 and ATR value of 0.28. The Weekly and Monthly Volatility stands at 3.87% and 4.98%.